Doctors at the New York University School of Medicine released a preliminary study last week that shows taking aspirin three times a week may reduce a woman’s risk of ovarian cancer by as much as 40 percent. The study, funded by the National Institutes of Health, found that aspirin could be an effective medication because it is anti-inflammatory, and chronic inflammation could be related to ovarian cancer, just as it is to endometriosis and pelvic inflammatory disease. The study was the fifth one looking at the relationship between aspirin and ovarian cancer. According to the American Cancer Society, ovarian cancer is the sixth most common cancer in women, and more than 23,000 American women will be diagnosed with the disease.
Uncategorized
